Health Care & Life Sciences » Pharmaceuticals | Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. | Ownership

Companies that own Vanda Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Consonance Capital Management LP
4,609,043
8.8%
1,536,768
4.76%
06/30/2018
BlackRock Fund Advisors
4,430,323
8.46%
655,973
0%
06/30/2018
Palo Alto Investors LP
4,155,670
7.93%
0
3.09%
06/30/2018
The Vanguard Group, Inc.
3,235,704
6.18%
181,249
0%
06/30/2018
venBio Select Advisor LLC
2,800,191
5.35%
25,000
1.85%
06/30/2018
Macquarie Investment Management Business Trust
2,555,004
4.88%
276,057
0.09%
06/30/2018
Armistice Capital LLC
2,224,000
4.25%
-376,000
3.27%
06/30/2018
SSgA Funds Management, Inc.
2,173,011
4.15%
288,921
0%
06/30/2018
Renaissance Technologies LLC
1,681,250
3.21%
41,200
0.03%
06/30/2018
Adage Capital Management LP
1,400,000
2.67%
0
0.06%
06/30/2018

About Vanda Pharmaceuticals

View Profile
Address
2200 Pennsylvania Avenue NW
Washington District of Columbia 20037
United States
Employees -
Website http://www.vandapharma.com
Updated 07/08/2019
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.